Latest news & insights
Trio of shortlistings for Boyds in TOPRA Awards 2024
The Boyds team has been shortlisted for three categories in the TOPRA Awards for Regulatory Excellence. The TOPRA Awards for Regulatory Excellence are the annual
Boyds announces four promotions
Boyds is pleased to announce the following promotions across the company.
Navigating the challenges of developing delivery devices for cell and gene therapy products in Europe
An article authored by Dr Patrick Ginty, Senior Director of Regulatory Affairs at Boyds, and Eamonn McGowran, Associate Director of Regulatory Affairs, has been published in Cell & Gene Therapy Insights’ August 2024 ‘Spotlight On’ innovation in cellular immunotherapy.
Medical student guest blog: my work placement at Boyds
Boyds recently welcomed fifth year medical student Sam Mayhew to the company for work experience, where he undertook a research project. In this guest blog,
Dr Harriet Gray Stephens completes Pharmaceutical Medicine Specialty Training
An article authored by Dr Harriet Gray Stephens MFPM, medical director at Boyds, has been published on the Clinical Leader website.
Dr Harriet Gray Stephens discusses the pros and cons of synthetic control arms in clinical trials
An article authored by Dr Harriet Gray Stephens MFPM, medical director at Boyds, has been published on the Clinical Leader website.
Chris Moore shares top tips for US biotechs setting up clinical studies in Europe
An article authored by Chris Moore, Clinical Project Manager at Boyds, has been featured by Clinical Leader.
Clinical pharmacology student completes internship with Boyds
Boyds recently welcomed Clinical Pharmacology BSc student Salma Muse to the team on a six-week internship.
